Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.
Saved in:
| Title: | Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis. |
|---|---|
| Authors: | Sacco, Rodolfo1 (AUTHOR) rsacco@ospedaliriunitifoggia.it, Giannini, Edoardo G.2 (AUTHOR), Tortora, Raffaella3 (AUTHOR), Di Costanzo, Giovan Giuseppe3,4 (AUTHOR), Mega, Andrea4,5 (AUTHOR), Marzi, Luca4,6 (AUTHOR), Pieri, Giulia2,7 (AUTHOR), Pasta, Andrea2,8 (AUTHOR), Daniele, Bruno5,9 (AUTHOR), Federico, Piera5,10 (AUTHOR), Cabibbo, Giuseppe6,11 (AUTHOR), Russello, Maurizio7,12 (AUTHOR), Cocuzza, Caterina7,13 (AUTHOR), Giacomelli, Luca8,14 (AUTHOR), Silletta, Marianna9,15 (AUTHOR), Gallo, Paolo10,16 (AUTHOR), Gentilucci, Umberto Vespasiani10,17 (AUTHOR), Casadei-Gardini, Andrea11,18 (AUTHOR), Claar, Ernesto12,19 (AUTHOR), Pellicelli, Adriano13,20 (AUTHOR) |
| Source: | Cancers. Jun2025, Vol. 17 Issue 11, p1808. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
